Literature DB >> 25202056

Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine.

Kentaro Minami1, Youhei Kamijo2, Yukihiko Nishizawa1, Sho Tabata3, Fumito Horikuchi2, Masatatsu Yamamoto4, Kohich Kawahara4, Yoshinari Shinsato4, Tokushi Tachiwada5, Zhe-Sheng Chen6, Kazutake Tsujikawa7, Masayuki Nakagawa8, Naohiko Seki9, Shin-Ichi Akiyama10, Kazunari Arima11, Yasuo Takeda12, Tatsuhiko Furukawa13.   

Abstract

A previously established arsenite-resistant cell line, KAS, is also resistant to a variety of anticancer drugs. In order to understand responsible molecules for the multidrug resistance phenotype of KAS cells, we examined the expressions of ATP-binding cassette (ABC) transporters and found that the ABCB6 and ABCC1/ multidrug resistance protein 1 (ABCC1/MRP1) were increased. ABCC1/MRP1 was not completely responsible for the drug resistance spectrum of KAS cells and several reports have suggested that ABCB6 is related to anticancer drug and metal resistance. We, therefore, established and examined ABCB6-expressing KB cells and ABCB6-knockdown KAS cells. ABCB6 expression enhanced resistance to 5-fluorouracil (5-FU), SN-38 and vincristine (Vcr) but not to arsenite. Conversely, down-regulation of ABCB6 in KAS cells increased the sensitivity of KAS cells to 5-FU, SN-38 and Vcr, but not to arsenite. Our findings suggest that ABCB6 is involved in 5-FU, SN-38 and Vcr resistance. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  ABC transporters; ABCB6; anticancer agents; arsenite; drug resistance

Mesh:

Substances:

Year:  2014        PMID: 25202056

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.

Authors:  Johan Nicolaï; Louise Thevelin; Qi Bing; Bruno Stieger; Hugues Chanteux; Patrick Augustijns; Pieter Annaert
Journal:  Pharm Res       Date:  2017-08-21       Impact factor: 4.200

Review 2.  ABCB6, an ABC Transporter Impacting Drug Response and Disease.

Authors:  Rebba C Boswell-Casteel; Yu Fukuda; John D Schuetz
Journal:  AAPS J       Date:  2017-11-30       Impact factor: 4.009

3.  Cryo-electron microscopy structure of human ABCB6 transporter.

Authors:  Chunyu Wang; Can Cao; Nan Wang; Xiangxi Wang; Xianping Wang; Xuejun C Zhang
Journal:  Protein Sci       Date:  2020-10-15       Impact factor: 6.725

4.  A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations.

Authors:  Daniel C Levings; Xuting Wang; Derek Kohlhase; Douglas A Bell; Matthew Slattery
Journal:  Redox Biol       Date:  2018-08-22       Impact factor: 11.799

5.  ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells.

Authors:  Changfu Liu; Wenge Xing; Haipeng Yu; Weihao Zhang; Tongguo Si
Journal:  Cancer Cell Int       Date:  2021-02-16       Impact factor: 5.722

Review 6.  Drug resistance: from bacteria to cancer.

Authors:  Harsh Patel; Zhuo-Xun Wu; Yanglu Chen; Letao Bo; Zhe-Sheng Chen
Journal:  Mol Biomed       Date:  2021-09-10

7.  Structural Insights into Porphyrin Recognition by the Human ATP-Binding Cassette Transporter ABCB6.

Authors:  Songwon Kim; Sang Soo Lee; Jun Gyou Park; Ji Won Kim; Seulgi Ju; Seung Hun Choi; Subin Kim; Na Jin Kim; Semi Hong; Jin Young Kang; Mi Sun Jin
Journal:  Mol Cells       Date:  2022-07-28       Impact factor: 4.250

Review 8.  Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma.

Authors:  Rachel L Mynott; Craig T Wallington-Beddoe
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-15

9.  Molecular insights into the human ABCB6 transporter.

Authors:  Guangyuan Song; Sensen Zhang; Mengqi Tian; Laixing Zhang; Runyu Guo; Wei Zhuo; Maojun Yang
Journal:  Cell Discov       Date:  2021-07-27       Impact factor: 10.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.